ArticleOncoimmunology

Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia.

Christian Kellner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.